| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |